img

Global Targeted Protein Degradation Market Size, Status and Forecast 2024-2034


Published on: 2024-01-04 | No of Pages : 282 | Industry : Medical Care

Publisher : MRA | Format : PDF

Global Targeted Protein Degradation Market Size, Status and Forecast 2024-2034

Global Targeted Protein Degradation Scope and Market Size
Targeted Protein Degradation market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Targeted Protein Degradation market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Oral
Intravenous
Others


Segment by Application


Hospital
Research Institute

By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA




By Company


5AM Venture Management LLC
AbbVie Inc
Almac Group
Amgen Inc.
Bayer AG
Biogen Inc.
C4 Therapeutics
Cosmo Bio USA
Covance Inc
Eli Lilly and Company
Gilead Sciences, Inc
GlaxoSmithKline plc
Merck KGaA
Mission Therapeutics
Novartis AG
Pfizer Inc
Promega

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Targeted Protein Degradation Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Oral
1.2.3 Intravenous
1.2.4 Others
1.3 Market by Application
1.3.1 Global Targeted Protein Degradation Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital
1.3.3 Research Institute
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Targeted Protein Degradation Market Perspective (2016-2027)
2.2 Targeted Protein Degradation Growth Trends by Regions
2.2.1 Targeted Protein Degradation Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Targeted Protein Degradation Historic Market Share by Regions (2016-2021)
2.2.3 Targeted Protein Degradation Forecasted Market Size by Regions (2022-2027)
2.3 Targeted Protein Degradation Industry Dynamic
2.3.1 Targeted Protein Degradation Market Trends
2.3.2 Targeted Protein Degradation Market Drivers
2.3.3 Targeted Protein Degradation Market Challenges
2.3.4 Targeted Protein Degradation Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Targeted Protein Degradation Players by Revenue
3.1.1 Global Top Targeted Protein Degradation Players by Revenue (2016-2021)
3.1.2 Global Targeted Protein Degradation Revenue Market Share by Players (2016-2021)
3.2 Global Targeted Protein Degradation Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Targeted Protein Degradation Revenue
3.4 Global Targeted Protein Degradation Market Concentration Ratio
3.4.1 Global Targeted Protein Degradation Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Targeted Protein Degradation Revenue in 2020
3.5 Targeted Protein Degradation Key Players Head office and Area Served
3.6 Key Players Targeted Protein Degradation Product Solution and Service
3.7 Date of Enter into Targeted Protein Degradation Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Targeted Protein Degradation Breakdown Data by Type
4.1 Global Targeted Protein Degradation Historic Market Size by Type (2016-2021)
4.2 Global Targeted Protein Degradation Forecasted Market Size by Type (2022-2027)

5 Targeted Protein Degradation Breakdown Data by Application
5.1 Global Targeted Protein Degradation Historic Market Size by Application (2016-2021)
5.2 Global Targeted Protein Degradation Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Targeted Protein Degradation Market Size (2016-2027)
6.2 North America Targeted Protein Degradation Market Size by Type
6.2.1 North America Targeted Protein Degradation Market Size by Type (2016-2021)
6.2.2 North America Targeted Protein Degradation Market Size by Type (2022-2027)
6.2.3 North America Targeted Protein Degradation Market Size by Type (2016-2027)
6.3 North America Targeted Protein Degradation Market Size by Application
6.3.1 North America Targeted Protein Degradation Market Size by Application (2016-2021)
6.3.2 North America Targeted Protein Degradation Market Size by Application (2022-2027)
6.3.3 North America Targeted Protein Degradation Market Size by Application (2016-2027)
6.4 North America Targeted Protein Degradation Market Size by Country
6.4.1 North America Targeted Protein Degradation Market Size by Country (2016-2021)
6.4.2 North America Targeted Protein Degradation Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Targeted Protein Degradation Market Size (2016-2027)
7.2 Europe Targeted Protein Degradation Market Size by Type
7.2.1 Europe Targeted Protein Degradation Market Size by Type (2016-2021)
7.2.2 Europe Targeted Protein Degradation Market Size by Type (2022-2027)
7.2.3 Europe Targeted Protein Degradation Market Size by Type (2016-2027)
7.3 Europe Targeted Protein Degradation Market Size by Application
7.3.1 Europe Targeted Protein Degradation Market Size by Application (2016-2021)
7.3.2 Europe Targeted Protein Degradation Market Size by Application (2022-2027)
7.3.3 Europe Targeted Protein Degradation Market Size by Application (2016-2027)
7.4 Europe Targeted Protein Degradation Market Size by Country
7.4.1 Europe Targeted Protein Degradation Market Size by Country (2016-2021)
7.4.2 Europe Targeted Protein Degradation Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Targeted Protein Degradation Market Size (2016-2027)
8.2 Asia-Pacific Targeted Protein Degradation Market Size by Type
8.2.1 Asia-Pacific Targeted Protein Degradation Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Targeted Protein Degradation Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Targeted Protein Degradation Market Size by Type (2016-2027)
8.3 Asia-Pacific Targeted Protein Degradation Market Size by Application
8.3.1 Asia-Pacific Targeted Protein Degradation Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Targeted Protein Degradation Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Targeted Protein Degradation Market Size by Application (2016-2027)
8.4 Asia-Pacific Targeted Protein Degradation Market Size by Region
8.4.1 Asia-Pacific Targeted Protein Degradation Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Targeted Protein Degradation Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Targeted Protein Degradation Market Size (2016-2027)
9.2 Latin America Targeted Protein Degradation Market Size by Type
9.2.1 Latin America Targeted Protein Degradation Market Size by Type (2016-2021)
9.2.2 Latin America Targeted Protein Degradation Market Size by Type (2022-2027)
9.2.3 Latin America Targeted Protein Degradation Market Size by Type (2016-2027)
9.3 Latin America Targeted Protein Degradation Market Size by Application
9.3.1 Latin America Targeted Protein Degradation Market Size by Application (2016-2021)
9.3.2 Latin America Targeted Protein Degradation Market Size by Application (2022-2027)
9.3.3 Latin America Targeted Protein Degradation Market Size by Application (2016-2027)
9.4 Latin America Targeted Protein Degradation Market Size by Country
9.4.1 Latin America Targeted Protein Degradation Market Size by Country (2016-2021)
9.4.2 Latin America Targeted Protein Degradation Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Targeted Protein Degradation Market Size (2016-2027)
10.2 Middle East & Africa Targeted Protein Degradation Market Size by Type
10.2.1 Middle East & Africa Targeted Protein Degradation Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Targeted Protein Degradation Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Targeted Protein Degradation Market Size by Type (2016-2027)
10.3 Middle East & Africa Targeted Protein Degradation Market Size by Application
10.3.1 Middle East & Africa Targeted Protein Degradation Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Targeted Protein Degradation Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Targeted Protein Degradation Market Size by Application (2016-2027)
10.4 Middle East & Africa Targeted Protein Degradation Market Size by Country
10.4.1 Middle East & Africa Targeted Protein Degradation Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Targeted Protein Degradation Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 5AM Venture Management LLC
11.1.1 5AM Venture Management LLC Company Details
11.1.2 5AM Venture Management LLC Business Overview
11.1.3 5AM Venture Management LLC Targeted Protein Degradation Introduction
11.1.4 5AM Venture Management LLC Revenue in Targeted Protein Degradation Business (2016-2021)
11.1.5 5AM Venture Management LLC Recent Development
11.2 AbbVie Inc
11.2.1 AbbVie Inc Company Details
11.2.2 AbbVie Inc Business Overview
11.2.3 AbbVie Inc Targeted Protein Degradation Introduction
11.2.4 AbbVie Inc Revenue in Targeted Protein Degradation Business (2016-2021)
11.2.5 AbbVie Inc Recent Development
11.3 Almac Group
11.3.1 Almac Group Company Details
11.3.2 Almac Group Business Overview
11.3.3 Almac Group Targeted Protein Degradation Introduction
11.3.4 Almac Group Revenue in Targeted Protein Degradation Business (2016-2021)
11.3.5 Almac Group Recent Development
11.4 Amgen Inc.
11.4.1 Amgen Inc. Company Details
11.4.2 Amgen Inc. Business Overview
11.4.3 Amgen Inc. Targeted Protein Degradation Introduction
11.4.4 Amgen Inc. Revenue in Targeted Protein Degradation Business (2016-2021)
11.4.5 Amgen Inc. Recent Development
11.5 Bayer AG
11.5.1 Bayer AG Company Details
11.5.2 Bayer AG Business Overview
11.5.3 Bayer AG Targeted Protein Degradation Introduction
11.5.4 Bayer AG Revenue in Targeted Protein Degradation Business (2016-2021)
11.5.5 Bayer AG Recent Development
11.6 Biogen Inc.
11.6.1 Biogen Inc. Company Details
11.6.2 Biogen Inc. Business Overview
11.6.3 Biogen Inc. Targeted Protein Degradation Introduction
11.6.4 Biogen Inc. Revenue in Targeted Protein Degradation Business (2016-2021)
11.6.5 Biogen Inc. Recent Development
11.7 C4 Therapeutics
11.7.1 C4 Therapeutics Company Details
11.7.2 C4 Therapeutics Business Overview
11.7.3 C4 Therapeutics Targeted Protein Degradation Introduction
11.7.4 C4 Therapeutics Revenue in Targeted Protein Degradation Business (2016-2021)
11.7.5 C4 Therapeutics Recent Development
11.8 Cosmo Bio USA
11.8.1 Cosmo Bio USA Company Details
11.8.2 Cosmo Bio USA Business Overview
11.8.3 Cosmo Bio USA Targeted Protein Degradation Introduction
11.8.4 Cosmo Bio USA Revenue in Targeted Protein Degradation Business (2016-2021)
11.8.5 Cosmo Bio USA Recent Development
11.9 Covance Inc
11.9.1 Covance Inc Company Details
11.9.2 Covance Inc Business Overview
11.9.3 Covance Inc Targeted Protein Degradation Introduction
11.9.4 Covance Inc Revenue in Targeted Protein Degradation Business (2016-2021)
11.9.5 Covance Inc Recent Development
11.10 Eli Lilly and Company
11.10.1 Eli Lilly and Company Company Details
11.10.2 Eli Lilly and Company Business Overview
11.10.3 Eli Lilly and Company Targeted Protein Degradation Introduction
11.10.4 Eli Lilly and Company Revenue in Targeted Protein Degradation Business (2016-2021)
11.10.5 Eli Lilly and Company Recent Development
11.11 Gilead Sciences, Inc
11.11.1 Gilead Sciences, Inc Company Details
11.11.2 Gilead Sciences, Inc Business Overview
11.11.3 Gilead Sciences, Inc Targeted Protein Degradation Introduction
11.11.4 Gilead Sciences, Inc Revenue in Targeted Protein Degradation Business (2016-2021)
11.11.5 Gilead Sciences, Inc Recent Development
11.12 GlaxoSmithKline plc
11.12.1 GlaxoSmithKline plc Company Details
11.12.2 GlaxoSmithKline plc Business Overview
11.12.3 GlaxoSmithKline plc Targeted Protein Degradation Introduction
11.12.4 GlaxoSmithKline plc Revenue in Targeted Protein Degradation Business (2016-2021)
11.12.5 GlaxoSmithKline plc Recent Development
11.13 Merck KGaA
11.13.1 Merck KGaA Company Details
11.13.2 Merck KGaA Business Overview
11.13.3 Merck KGaA Targeted Protein Degradation Introduction
11.13.4 Merck KGaA Revenue in Targeted Protein Degradation Business (2016-2021)
11.13.5 Merck KGaA Recent Development
11.14 Mission Therapeutics
11.14.1 Mission Therapeutics Company Details
11.14.2 Mission Therapeutics Business Overview
11.14.3 Mission Therapeutics Targeted Protein Degradation Introduction
11.14.4 Mission Therapeutics Revenue in Targeted Protein Degradation Business (2016-2021)
11.14.5 Mission Therapeutics Recent Development
11.15 Novartis AG
11.15.1 Novartis AG Company Details
11.15.2 Novartis AG Business Overview
11.15.3 Novartis AG Targeted Protein Degradation Introduction
11.15.4 Novartis AG Revenue in Targeted Protein Degradation Business (2016-2021)
11.15.5 Novartis AG Recent Development
11.16 Pfizer Inc
11.16.1 Pfizer Inc Company Details
11.16.2 Pfizer Inc Business Overview
11.16.3 Pfizer Inc Targeted Protein Degradation Introduction
11.16.4 Pfizer Inc Revenue in Targeted Protein Degradation Business (2016-2021)
11.16.5 Pfizer Inc Recent Development
11.17 Promega
11.17.1 Promega Company Details
11.17.2 Promega Business Overview
11.17.3 Promega Targeted Protein Degradation Introduction
11.17.4 Promega Revenue in Targeted Protein Degradation Business (2016-2021)
11.17.5 Promega Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Targeted Protein Degradation Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Oral
Table 3. Key Players of Intravenous
Table 4. Key Players of Others
Table 5. Global Targeted Protein Degradation Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Targeted Protein Degradation Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Targeted Protein Degradation Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Targeted Protein Degradation Market Share by Regions (2016-2021)
Table 9. Global Targeted Protein Degradation Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Targeted Protein Degradation Market Share by Regions (2022-2027)
Table 11. Targeted Protein Degradation Market Trends
Table 12. Targeted Protein Degradation Market Drivers
Table 13. Targeted Protein Degradation Market Challenges
Table 14. Targeted Protein Degradation Market Restraints
Table 15. Global Targeted Protein Degradation Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Targeted Protein Degradation Market Share by Players (2016-2021)
Table 17. Global Top Targeted Protein Degradation Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Targeted Protein Degradation as of 2020)
Table 18. Ranking of Global Top Targeted Protein Degradation Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Targeted Protein Degradation Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Targeted Protein Degradation Product Solution and Service
Table 22. Date of Enter into Targeted Protein Degradation Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Targeted Protein Degradation Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Targeted Protein Degradation Revenue Market Share by Type (2016-2021)
Table 26. Global Targeted Protein Degradation Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Targeted Protein Degradation Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Targeted Protein Degradation Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Targeted Protein Degradation Revenue Market Share by Application (2016-2021)
Table 30. Global Targeted Protein Degradation Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Targeted Protein Degradation Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Targeted Protein Degradation Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Targeted Protein Degradation Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Targeted Protein Degradation Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Targeted Protein Degradation Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Targeted Protein Degradation Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Targeted Protein Degradation Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Targeted Protein Degradation Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Targeted Protein Degradation Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Targeted Protein Degradation Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Targeted Protein Degradation Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Targeted Protein Degradation Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Targeted Protein Degradation Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Targeted Protein Degradation Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Targeted Protein Degradation Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Targeted Protein Degradation Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Targeted Protein Degradation Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Targeted Protein Degradation Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Targeted Protein Degradation Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Targeted Protein Degradation Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Targeted Protein Degradation Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Targeted Protein Degradation Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Targeted Protein Degradation Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Targeted Protein Degradation Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Targeted Protein Degradation Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Targeted Protein Degradation Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Targeted Protein Degradation Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Targeted Protein Degradation Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Targeted Protein Degradation Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Targeted Protein Degradation Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Targeted Protein Degradation Market Size by Country (2022-2027) & (US$ Million)
Table 62. 5AM Venture Management LLC Company Details
Table 63. 5AM Venture Management LLC Business Overview
Table 64. 5AM Venture Management LLC Targeted Protein Degradation Product
Table 65. 5AM Venture Management LLC Revenue in Targeted Protein Degradation Business (2016-2021) & (US$ Million)
Table 66. 5AM Venture Management LLC Recent Development
Table 67. AbbVie Inc Company Details
Table 68. AbbVie Inc Business Overview
Table 69. AbbVie Inc Targeted Protein Degradation Product
Table 70. AbbVie Inc Revenue in Targeted Protein Degradation Business (2016-2021) & (US$ Million)
Table 71. AbbVie Inc Recent Development
Table 72. Almac Group Company Details
Table 73. Almac Group Business Overview
Table 74. Almac Group Targeted Protein Degradation Product
Table 75. Almac Group Revenue in Targeted Protein Degradation Business (2016-2021) & (US$ Million)
Table 76. Almac Group Recent Development
Table 77. Amgen Inc. Company Details
Table 78. Amgen Inc. Business Overview
Table 79. Amgen Inc. Targeted Protein Degradation Product
Table 80. Amgen Inc. Revenue in Targeted Protein Degradation Business (2016-2021) & (US$ Million)
Table 81. Amgen Inc. Recent Development
Table 82. Bayer AG Company Details
Table 83. Bayer AG Business Overview
Table 84. Bayer AG Targeted Protein Degradation Product
Table 85. Bayer AG Revenue in Targeted Protein Degradation Business (2016-2021) & (US$ Million)
Table 86. Bayer AG Recent Development
Table 87. Biogen Inc. Company Details
Table 88. Biogen Inc. Business Overview
Table 89. Biogen Inc. Targeted Protein Degradation Product
Table 90. Biogen Inc. Revenue in Targeted Protein Degradation Business (2016-2021) & (US$ Million)
Table 91. Biogen Inc. Recent Development
Table 92. C4 Therapeutics Company Details
Table 93. C4 Therapeutics Business Overview
Table 94. C4 Therapeutics Targeted Protein Degradation Product
Table 95. C4 Therapeutics Revenue in Targeted Protein Degradation Business (2016-2021) & (US$ Million)
Table 96. C4 Therapeutics Recent Development
Table 97. Cosmo Bio USA Company Details
Table 98. Cosmo Bio USA Business Overview
Table 99. Cosmo Bio USA Revenue in Targeted Protein Degradation Business (2016-2021) & (US$ Million)
Table 100. Cosmo Bio USA Recent Development
Table 101. Covance Inc Company Details
Table 102. Covance Inc Business Overview
Table 103. Covance Inc Targeted Protein Degradation Product
Table 104. Covance Inc Revenue in Targeted Protein Degradation Business (2016-2021) & (US$ Million)
Table 105. Covance Inc Recent Development
Table 106. Eli Lilly and Company Company Details
Table 107. Eli Lilly and Company Business Overview
Table 108. Eli Lilly and Company Targeted Protein Degradation Product
Table 109. Eli Lilly and Company Revenue in Targeted Protein Degradation Business (2016-2021) & (US$ Million)
Table 110. Eli Lilly and Company Recent Development
Table 111. Gilead Sciences, Inc Company Details
Table 112. Gilead Sciences, Inc Business Overview
Table 113. Gilead Sciences, Inc Targeted Protein Degradation Product
Table 114. Gilead Sciences, Inc Revenue in Targeted Protein Degradation Business (2016-2021) & (US$ Million)
Table 115. Gilead Sciences, Inc Recent Development
Table 116. GlaxoSmithKline plc Company Details
Table 117. GlaxoSmithKline plc Business Overview
Table 118. GlaxoSmithKline plc Targeted Protein Degradation Product
Table 119. GlaxoSmithKline plc Revenue in Targeted Protein Degradation Business (2016-2021) & (US$ Million)
Table 120. GlaxoSmithKline plc Recent Development
Table 121. Merck KGaA Company Details
Table 122. Merck KGaA Business Overview
Table 123. Merck KGaA Targeted Protein Degradation Product
Table 124. Merck KGaA Revenue in Targeted Protein Degradation Business (2016-2021) & (US$ Million)
Table 125. Merck KGaA Recent Development
Table 126. Mission Therapeutics Company Details
Table 127. Mission Therapeutics Business Overview
Table 128. Mission Therapeutics Targeted Protein Degradation Product
Table 129. Mission Therapeutics Revenue in Targeted Protein Degradation Business (2016-2021) & (US$ Million)
Table 130. Mission Therapeutics Recent Development
Table 131. Novartis AG Company Details
Table 132. Novartis AG Business Overview
Table 133. Novartis AG Targeted Protein Degradation Product
Table 134. Novartis AG Revenue in Targeted Protein Degradation Business (2016-2021) & (US$ Million)
Table 135. Novartis AG Recent Development
Table 136. Pfizer Inc Company Details
Table 137. Pfizer Inc Business Overview
Table 138. Pfizer Inc Targeted Protein Degradation Product
Table 139. Pfizer Inc Revenue in Targeted Protein Degradation Business (2016-2021) & (US$ Million)
Table 140. Pfizer Inc Recent Development
Table 141. Promega Company Details
Table 142. Promega Business Overview
Table 143. Promega Targeted Protein Degradation Product
Table 144. Promega Revenue in Targeted Protein Degradation Business (2016-2021) & (US$ Million)
Table 145. Promega Recent Development
Table 146. Research Programs/Design for This Report
Table 147. Key Data Information from Secondary Sources
Table 148. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Targeted Protein Degradation Market Share by Type: 2020 VS 2027
Figure 2. Oral Features
Figure 3. Intravenous Features
Figure 4. Others Features
Figure 5. Global Targeted Protein Degradation Market Share by Application: 2020 VS 2027
Figure 6. Hospital Case Studies
Figure 7. Research Institute Case Studies
Figure 8. Targeted Protein Degradation Report Years Considered
Figure 9. Global Targeted Protein Degradation Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 10. Global Targeted Protein Degradation Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Targeted Protein Degradation Market Share by Regions: 2020 VS 2027
Figure 12. Global Targeted Protein Degradation Market Share by Regions (2022-2027)
Figure 13. Global Targeted Protein Degradation Market Share by Players in 2020
Figure 14. Global Top Targeted Protein Degradation Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Targeted Protein Degradation as of 2020
Figure 15. The Top 10 and 5 Players Market Share by Targeted Protein Degradation Revenue in 2020
Figure 16. Global Targeted Protein Degradation Revenue Market Share by Type (2016-2021)
Figure 17. Global Targeted Protein Degradation Revenue Market Share by Type (2022-2027)
Figure 18. North America Targeted Protein Degradation Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 19. North America Targeted Protein Degradation Market Share by Type (2016-2027)
Figure 20. North America Targeted Protein Degradation Market Share by Application (2016-2027)
Figure 21. North America Targeted Protein Degradation Market Share by Country (2016-2027)
Figure 22. United States Targeted Protein Degradation Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Canada Targeted Protein Degradation Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Targeted Protein Degradation Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Targeted Protein Degradation Market Share by Type (2016-2027)
Figure 26. Europe Targeted Protein Degradation Market Share by Application (2016-2027)
Figure 27. Europe Targeted Protein Degradation Market Share by Country (2016-2027)
Figure 28. Germany Targeted Protein Degradation Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. France Targeted Protein Degradation Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. U.K. Targeted Protein Degradation Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Italy Targeted Protein Degradation Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Russia Targeted Protein Degradation Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Nordic Targeted Protein Degradation Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Targeted Protein Degradation Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Targeted Protein Degradation Market Share by Type (2016-2027)
Figure 36. Asia-Pacific Targeted Protein Degradation Market Share by Application (2016-2027)
Figure 37. Asia-Pacific Targeted Protein Degradation Market Share by Region (2016-2027)
Figure 38. China Targeted Protein Degradation Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Japan Targeted Protein Degradation Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. South Korea Targeted Protein Degradation Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Southeast Asia Targeted Protein Degradation Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. India Targeted Protein Degradation Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Australia Targeted Protein Degradation Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Targeted Protein Degradation Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Targeted Protein Degradation Market Share by Type (2016-2027)
Figure 46. Latin America Targeted Protein Degradation Market Share by Application (2016-2027)
Figure 47. Latin America Targeted Protein Degradation Market Share by Country (2016-2027)
Figure 48. Mexico Targeted Protein Degradation Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Brazil Targeted Protein Degradation Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Targeted Protein Degradation Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Targeted Protein Degradation Market Share by Type (2016-2027)
Figure 52. Middle East & Africa Targeted Protein Degradation Market Share by Application (2016-2027)
Figure 53. Middle East & Africa Targeted Protein Degradation Market Share by Country (2016-2027)
Figure 54. Turkey Targeted Protein Degradation Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Saudi Arabia Targeted Protein Degradation Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. UAE Targeted Protein Degradation Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. 5AM Venture Management LLC Revenue Growth Rate in Targeted Protein Degradation Business (2016-2021)
Figure 58. AbbVie Inc Revenue Growth Rate in Targeted Protein Degradation Business (2016-2021)
Figure 59. Almac Group Revenue Growth Rate in Targeted Protein Degradation Business (2016-2021)
Figure 60. Amgen Inc. Revenue Growth Rate in Targeted Protein Degradation Business (2016-2021)
Figure 61. Bayer AG Revenue Growth Rate in Targeted Protein Degradation Business (2016-2021)
Figure 62. Biogen Inc. Revenue Growth Rate in Targeted Protein Degradation Business (2016-2021)
Figure 63. C4 Therapeutics Revenue Growth Rate in Targeted Protein Degradation Business (2016-2021)
Figure 64. Cosmo Bio USA Revenue Growth Rate in Targeted Protein Degradation Business (2016-2021)
Figure 65. Covance Inc Revenue Growth Rate in Targeted Protein Degradation Business (2016-2021)
Figure 66. Eli Lilly and Company Revenue Growth Rate in Targeted Protein Degradation Business (2016-2021)
Figure 67. Gilead Sciences, Inc Revenue Growth Rate in Targeted Protein Degradation Business (2016-2021)
Figure 68. GlaxoSmithKline plc Revenue Growth Rate in Targeted Protein Degradation Business (2016-2021)
Figure 69. Merck KGaA Revenue Growth Rate in Targeted Protein Degradation Business (2016-2021)
Figure 70. Mission Therapeutics Revenue Growth Rate in Targeted Protein Degradation Business (2016-2021)
Figure 71. Novartis AG Revenue Growth Rate in Targeted Protein Degradation Business (2016-2021)
Figure 72. Pfizer Inc Revenue Growth Rate in Targeted Protein Degradation Business (2016-2021)
Figure 73. Promega Revenue Growth Rate in Targeted Protein Degradation Business (2016-2021)
Figure 74. Bottom-up and Top-down Approaches for This Report
Figure 75. Data Triangulation
Figure 76. Key Executives Interviewed